Brookline, MA, United States of America

Bert L Vallee

This inventor holds 27 USPTO granted patents, primarily in Angiogenesis Research. Top assignees: Harvard College, The Endowment for Research in Human Biology, Inc.. Active years: 1978-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bert L Vallee. Retrieved from https://idiyas.com/inventor/bert-l-vallee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 13

Forward Citations = 427(Granted Patents)


Location History:

  • Waltham, MA (US) (1988)
  • Brookline, MA (US) (1978 - 2001)
  • Boston, MA (US) (2000 - 2008)

Company Filing History:


Years Active: 1978-2008

Loading Chart...
Areas of Expertise:
ALDH Inhibition
Angiogenin
Alcohol Dependence
Immunotherapeutic Agents
Ribonucleases
Meniscal Tissue Healing
Isozyme Measurement
Purified Proteins
Gene Methods
Covalent Hybrids
Tumor-Secreted Products
Affinity Resin
27 patents (USPTO):Explore Patents

Title: Innovations and Achievements of Bert L Vallee

Introduction

Bert L Vallee, a prominent figure in the field of biochemistry and pharmacology, is based in Brookline, MA, USA. With an impressive portfolio of 27 patents, he has significantly contributed to advancements in medical research, particularly in the areas of alcohol consumption modulation and angiogenesis-related diseases.

Latest Patents

Bert L Vallee's latest patents include two notable inventions. The first patent involves "Compounds useful for the inhibition of ALDH," which presents novel antidipsotropic compounds designed to inhibit ALDH-2. This invention not only introduces methods for modulating alcohol consumption, dependence, and abuse but also lays the groundwork for developing additional innovative antidipsotropic compounds. The second patent focuses on "Use of neomycin for treating angiogenesis-related diseases." This invention proposes the use of neomycin or its analogues as therapeutic agents for conditions characterized by excessive or inappropriate angiogenesis. It includes pharmaceutical compositions that combine neomycin with anti-angiogenic or anti-neoplastic agents, along with methods for screening neomycin analogues for anti-angiogenic activity.

Career Highlights

Throughout his illustrious career, Bert L Vallee has held significant positions in esteemed institutions such as the President and Fellows of Harvard College and The Endowment for Research in Human Biology, Inc. His work in these organizations has fostered groundbreaking research and innovation, further establishing his reputation as a leading inventor in the scientific community.

Collaborations

Bert has collaborated with notable scientists such as James W Fett and Wing-Ming Keung, contributing to a dynamic research environment that promotes the exchange of ideas and innovative solutions. These collaborations have been crucial in advancing the scientific understanding of complex biological processes and therapeutic approaches.

Conclusion

Bert L Vallee’s contributions to science and medicine through his extensive patent portfolio illustrate his dedication to innovation and his impactful research. His work continues to inspire and guide future discoveries in the fields of pharmacology and biochemistry, showcasing the essential role of inventors in shaping health-related advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…